Monthly Publications
In Depth
Subscribe Now
In Depth
coverage of timely
Life Science
Compliance issues
Subscribe Now
Browsing Category
State Policy
Oklahoma Requires CME for Prescribers
Many states have taken the cue from the federal government and started their own investigation and research into opioids and the…
Maine Passes Drug Transparency Law – A Study
We try to keep our readers in the loop with transparency and other related legislation that are happening throughout the country.…
Circuit Court Strikes Blow to Maryland Drug Pricing Measure
On April 13, 2018, the United States of Appeals for the Fourth Circuit struck down the first-in-the-nation law aimed at lowering…
Maine and Colorado: Making Moves on Drug Price Transparency?
We have been keeping up with proposed and passed legislation in several states that affect the pharmaceutical industry, especially…
State of Washington Enacts Statewide Drug Disposal Law
On March 22, 2018, the State of Washington officially enacted the first statewide drug take-back program in the country.…
Oregon: Transparency’s Latest Frontier
On March 13, 2018, Oregon Governor Kate Brown signed a bill that requires drugmakers to reportresearch and development and…
Checking In: Are Your State Legislators Concentrating on Drug-Price…
Price transparency is such a hot topic today that it is oftentimes hard to keep up with the different state legislatures that are…
New Jersey “Gift” Ban Revision?
During his last few days as Governor of New Jersey, Chris Christie’s administration enacted an aggressive regulation in an stated…
Transparency Bill Reintroduced in Oregon
During the 2017 Oregon Legislature session, Senator Steiner Hayward and Representative Rob Nosse introduced legislation on…
Nevada Posts FAQ and Reporting Requirements on Transparency Law
As we posted last week, the Nevada draft regulations are up and starting to become a hot topic. The same day as our last post,…